Literature DB >> 12423429

Molecular and cellular biology of basal cell carcinoma.

Tony Dicker1, Gregory Siller, Nicholas Saunders.   

Abstract

The finding of mutations in the PTCH gene in both Gorlin's syndrome and sporadic basal cell carcinomas has significantly advanced our understanding of the molecular defects that lead to the formation of these tumours. Knowledge of the specific molecular and functional changes that have taken place in these tumours will help us devise more defined therapies, as well as give us a better understanding of normal molecular pathways involved in skin development and function. The following is a summary of our current understanding of the molecular and cellular biology of basal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12423429     DOI: 10.1046/j.1440-0960.2002.00609.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  4 in total

1.  Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice.

Authors:  Simin Arad; Edoardo Zattra; Jennifer Hebert; Ervin H Epstein; David A Goukassian; Barbara A Gilchrest
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

2.  Cyclin D1 expression in Bowen's disease and cutaneous squamous cell carcinoma.

Authors:  Yanyun Shen; Jinhua Xu; Jin Jin; Hui Tang; Jun Liang
Journal:  Mol Clin Oncol       Date:  2014-04-01

3.  Identification of Potential Biomarkers Associated with Basal Cell Carcinoma.

Authors:  Yong Liu; Hui Liu; Queqiao Bian
Journal:  Biomed Res Int       Date:  2020-04-17       Impact factor: 3.411

4.  Direct long bone invasion by Basal cell carcinoma: a case report and review of the literature.

Authors:  Badr M Al Majed; Stephanie L Koonce; Dustin L Eck; Peter Murray; Galen Perdikis
Journal:  Eplasty       Date:  2013-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.